Dipanwita Das has dedicated her career to closing the gap between scientific discovery and patient care, ensuring that for patients who "can't wait," the wait is finally getting shorter. As CEO and Co-founder of Sorcero, she is reshaping the life sciences commercial model, pivoting the industry away from legacy promotional outreach and toward evidence-based, medically-led intelligence. She has been recognized as a Sir Edmund Hillary Fellow, and prior to Sorcero built the digital platform for a public health initiative reaching over three billion people, bringing that same drive for large-scale human impact to every problem she tackles.